米国と欧州の代理出産市場の2030年までの予測-タイプ、技術、年齢層、サービス別：国別分析

米国と欧州の代理出産市場規模は、2022年の61億1,372万米ドルから2030年には252億8,402万米ドルに成長すると予測されており、2022年から2030年までのCAGRは19.4％と推定されています。

不妊症患者の増加と不妊治療に対する意識の高まりが、米国と欧州の代理出産市場の成長を牽引しています。また、代理出産の商業化が米国と欧州の代理出産市場の成長を今後数年間促進すると予想されます。

代理出産とは、女性が他の個人やカップルに代わって妊娠・出産することであり、一般的に意図された両親と呼ばれます。夫婦が自分達で妊娠を望まない場合、妊娠が物理的に不可能な場合、妊娠のリスクが母体にとって危険な場合、独身男性や男性夫婦が子供を持ちたい場合、人々は代理出産の手配を調べることがあります。

不妊治療に対する意識の高まりが米国と欧州の代理出産市場の成長を後押ししています。

遺伝、免疫性不妊、性感染症（STI）、卵管閉塞、子宮筋腫などは不妊を引き起こす要因の一部です。CDCが発表したデータによると、米国では8組に1組のカップルが妊娠困難に直面しており、すなわち、既婚女性の12％以上が妊娠を達成するために合併症に直面しています。2023年にMedical Lifesciences誌に発表されたデータによると、この問題は英国では7組に1組のカップルに影響を及ぼし、合計で350万人が影響を受けています。代理出産を含め、不妊を克服するために利用できる様々な選択肢があることを知る人が増えるにつれ、代理出産サービスの需要が高まっています。いくつかの民間団体や公的団体は、体外受精（IVF）や子宮内人工授精（IUI）などの方法を推進するイニシアチブを通じて、不妊症とその治療に対する認識を広めています。米国Fertilityは、不妊症に悩む人々に、毎年4月最終週に開催されるNational Infertility Awareness Week（NIAW）への参加を呼びかけています。NIAWの期間中、Fertility Centres of Illinois（FCI）, IVF Florida, Reproductive Science Centre of the San Francisco Bay Area（RSC）, Shady Grove Fertility（SGF）では、医師主催のイベントを開催し、患者を啓発するための教材を用意しています。さらに、欧州では毎年11月に欧州不妊週間が開催され、不妊に対する認識を高めています。このように、不妊治療に関する啓蒙活動の増加は、米国と欧州の代理出産市場を後押ししています。

高い費用が米国と欧州の代理出産市場の成長を妨げています。

多くの個人やカップルが、比較的医療費の安い国での国際的な代理出産を選択しています。インド、ウクライナ、東南アジア諸国などは、より安価な代理出産を求める人々に人気のある国です。これらの国々は、医療費が安く、法的要件が厳しくなく、代理母への報酬が低いため、全体的な出費が抑えられることが多いです。メディカル・ツーリズムのコンサルタント会社であるIVF Conceptionによると、インドでの代理出産の費用は12～15万インドルピー（15,000～21,000米ドル）で、米国や東欧諸国に比べてかなり低いです。一方、米国やウクライナなどの東欧諸国における代理出産の一般的な費用は、それぞれ95,000～150,000米ドル、45,000～55,000米ドルです。

また、代理出産の手続きには多額の費用がかかります。代理出産の意向を持つ両親は、すべての法的側面が適切に処理されるように、代理出産法を専門とする専門家に相談する必要があります。これには、契約書の作成や見直し、必要な許可や書類の取得、代理出産を取り巻く複雑な法的状況の把握などが含まれます。さらに、その他の雑費として、意中の両親のための旅費、宿泊の手配、保険の適用、旅を通して発生する追加的な不測の事態などがあります。これらの費用は、個々の状況や取り決めの具体的な要件によって異なります。従って、代理出産にかかる高額な費用は、一部の意中の両親にとって障壁となり、市場全体の成長を制限する可能性があります。

米国と欧州の代理出産市場における最近の開拓のいくつかを以下に述べる：

2023年3月、米国Fertility社はOvation Fertility社と提携し、体外受精サービスの強国を築き、不妊治療サービスへのアクセスを増加させる。両社は最終合意に調印し、連邦規制当局の評価プロセスも完了し、米国をリードする不妊治療プラットフォームが誕生しました。

2023年5月、ロンドン・ウィメンズ・クリニックはコルチェスターに新しい不妊治療クリニックを開設しました。これにより、同社はエセックス郡とその周辺地域を通じて、世界クラスの不妊治療を誇りを持って拡大することができます。

米国と欧州の代理出産市場に関する洞察

米国と欧州の代理出産市場は、タイプ別に伝統的代理出産と妊娠代理出産に区分されます。2022年、米国と欧州の代理出産市場では、妊娠中代理出産が最大の市場シェアを占めています。同分野の市場は今後数年で最も速い速度で成長すると予想されます。

米国と欧州の代理出産市場-技術的洞察

米国と欧州の代理出産市場は、技術によって子宮内人工授精と体外受精に区分されます。2022年、米国と欧州の代理出産市場では、体外受精分野が最大の市場シェアを占めています。同分野の市場は今後数年で最も速い速度で成長すると予想されます。

米国と欧州の代理出産市場の年齢層別の洞察

米国と欧州の代理出産市場は年齢層に基づき、35歳以下、35-37歳、38-39歳、40-42歳、43-44歳、44歳以上に区分されます。2022年には、35歳以下が最大の市場シェアを占め、予測期間中、同セグメントが最も速い速度で成長すると予測されています。

サービスオーダー米国と欧州の代理出産市場に基づく洞察

米国と欧州の代理出産市場は、サービスオーダーに基づいて、病院、不妊治療クリニック、その他に区分されます。2022年には不妊治療クリニックが最大の市場シェアを占め、予測期間中、同セグメントが最も速い速度で成長すると予測されています。

世界保健機関（WHO）、米国疾病予防管理センター（CDC）、米国不妊治療サービス（American Fertility Services）などは、米国と欧州の代理出産市場に関する報告書を作成する際に参照した主な一次情報および二次情報の一部です。

目次

第1章 イントロダクション

第2章 米国と欧州の代理出産市場-要点

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 米国と欧州の代理出産市場-市場情勢

• 概観
• PEST分析
  • 米国-PEST分析
  • 欧州-PEST分析

第5章 米国と欧州の代理出産市場-主要市場力学

• 市場促進要因
  • 不妊症患者数の増加
  • 不妊治療に対する意識の高まり
• 市場抑制要因
  • 不妊治療にかかる費用の高さ
• 市場機会
  • 生殖技術の技術的進歩
• 今後の動向
  • 代理出産の商業化
• 影響分析

第6章 米国と欧州の代理出産市場分析

• 米国と欧州の代理出産市場の収益と予測分析
• 費用分析
• 規制シナリオ
  • 米国
  • イタリア
  • 英国
  • デンマーク
  • オランダ
  • アイルランド

第7章 米国と欧州の代理出産市場分析-タイプ別

• 妊娠中代理出産
• 伝統的代理出産

第8章 米国と欧州の代理出産市場分析-技術別

• 子宮内人工授精（IUI）
• 体外受精（IVF）

第9章 米国と欧州の代理出産市場分析-年齢層別

• 35歳以下
• 37歳以下
• 39歳以下
• 42歳以下
• 44歳以下
• 44歳以上

第10章 米国と欧州の代理出産市場分析-サービスオーダー別

• 病院
• 不妊治療クリニック
• その他

第11章 米国と欧州の代理出産市場-地域分析

• 欧州
  • 欧州代理出産市場：タイプ別、2020～2030年
  • 欧州代理出産市場：技術別、2020～2030年
    • 欧州代理出産市場：体外受精（技術別）、2020～2030年
  • 欧州代理出産市場：年齢層別、2020～2030年
  • 欧州代理出産市場：サービスオーダー別、2020～2030年
  • 欧州代理出産市場：国別
    • イタリア
    • 英国
    • デンマーク
    • オランダ
    • アイルランド
    • その他の欧州
• 米国
  • 米国代理出産市場：タイプ別、2020～2030年
  • 米国代理出産市場：技術別、2020～2030年
    • 米国代理出産市場：体外受精（技術別）、2020～2030年
  • 米国代理出産市場：年齢層別、2020～2030年
  • 米国代理出産市場：サービスオーダー別、2020～2030年

第12章 COVID-19パンデミックが米国と欧州の代理出産市場に与える影響

• 米国
• 欧州

第13章 米国と欧州の代理出産市場-業界情勢

• 米国と欧州の代理出産市場の成長戦略（%）
• 有機的展開
• 無機的展開

第14章 企業プロファイル

• London Women's Clinic Ltd
• The Centre for Reproductive and Genetic Health Ltd
• Miracle Baby Surrogacy
• Lotus Surrogacy
• VittoriaVita LLC
• Sensible Surrogacy
• New Life Ukraine
• Redia Ltd
• Circle Surrogacy LLC
• Ovation Fertility

第15章 付録

List Of Tables

• Table 1. Cost Analysis
• Table 2. Europe Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 3. Europe Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 4. Europe Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 5. Europe Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 6. Europe Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 7. Italy Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 8. Italy Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 9. Italy Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 10. Italy Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 11. Italy Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 12. UK Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 13. UK Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 14. UK Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 15. UK Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 16. UK Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 17. Denmark Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 18. Denmark Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 19. Denmark Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 20. Denmark Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 21. Denmark Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 22. The Netherlands Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 23. The Netherlands Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 24. The Netherlands Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 25. The Netherlands Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 26. The Netherlands Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 27. Ireland Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 28. Ireland Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 29. Ireland Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 30. Ireland Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 31. Ireland Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 32. Rest of Europe Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 33. Rest of Europe Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 34. Rest of Europe Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 35. Rest of Europe Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 36. Rest of Europe Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 37. US Surrogacy Market, by Type - Revenue and Forecast to 2030 (US$ Million)
• Table 38. US Surrogacy Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 39. US Surrogacy Market, for IVF by Technology - Revenue and Forecast to 2030 (US$ Million)
• Table 40. US Surrogacy Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
• Table 41. US Surrogacy Market, by Service Order - Revenue and Forecast to 2030 (US$ Million)
• Table 42. Organic Developments in the USA & Europe Surrogacy Market
• Table 43. Inorganic Developments in the USA & Europe Surrogacy Market
• Table 44. Glossary of Terms

List Of Figures

• Figure 1. US and Europe Surrogacy market Segmentation
• Figure 2. US and Europe Surrogacy market Segmentation, by Country
• Figure 3. US and Europe Surrogacy market Overview
• Figure 4. Gestation Largest Share of Type Segment in US and Europe Surrogacy Market
• Figure 5. Europe Expected to Show Remarkable Growth During Forecast Period
• Figure 6. US and Europe Surrogacy market - Leading Country Markets (US$ Million)
• Figure 7. US and Europe Surrogacy Market, Industry Landscape
• Figure 8. US PEST Analysis
• Figure 9. Europe PEST Analysis
• Figure 10. Surrogacy Market: Impact Analysis of Drivers and Restraints
• Figure 11. US and Europe Surrogacy market - Revenue Forecast and Analysis - 2020-2030
• Figure 12. US and Europe Surrogacy Market, by Type, 2022 & 2030 (%)
• Figure 13. Gestational Surrogacy: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 14. Traditional Surrogacy: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 15. US and Europe Surrogacy Market, by Type, 2022 & 2030 (%)
• Figure 16. Intrauterine Insemination (IUI): US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. In-Vitro Fertilization (IVF): US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Classical/Standard IVF: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. Intracytoplasmic Sperm Injection (ICSI): US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 20. US and Europe Surrogacy Market, by Age Group, 2022 & 2030 (%)
• Figure 21. Below 35 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22.-37 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 23.-39 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24.-42 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 25.-44 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 26. Over 44 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 27. US and Europe Surrogacy Market, by Service Order, 2022 & 2030 (%)
• Figure 28. Hospitals: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 29. Fertility Clinics: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 30. Others: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 31. Europe Surrogacy Market Revenue Overview, by Country, 2022 (US$ Mn)
• Figure 32. Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 33. Europe Surrogacy Market, by Country, 2022 & 2030 (%)
• Figure 34. Italy Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 35. UK Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 36. Denmark Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 37. The Netherlands Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 38. Ireland Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 39. Rest of Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 40. US Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
• Figure 41. Impact of COVID-19 Pandemic in United States Markets
• Figure 42. Impact of COVID-19 Pandemic in European Country Markets
• Figure 43. Growth Strategies in USA & Europe Surrogacy Market (%)

The US and Europe surrogacy market size is expected to grow from US$ 6,113.72 million in 2022 to US$ 25,284.02 million by 2030; it is estimated to register a CAGR of 19.4% from 2022 to 2030.

The increase in infertility cases and growing awareness of the treatment of fertility drive the US and Europe surrogacy market growth. Also, commercialization of surrogacy is expected to fuel the US and Europe surrogacy market growth in the coming years.

Surrogacy is a practice where a woman carries a pregnancy and gives birth to a child on behalf of another individual or couple, commonly referred to as intended parents. When a couple doesn't want to bear the pregnancy themselves, when pregnancy is physically impossible, when pregnancy risks are risky for the intended mother, or when a single man or a male couple wants to have a kid, people may investigate surrogacy arrangements.

Growing Awareness of Treatment of Infertility is fueling the growth of the US and Europe Surrogacy Market

Genetics, immune infertility, sexually transmitted infections (STIs), tubal blockage, and uterine fibroids are a few of the factors causing infertility. As per data published by CDC, every 1 in 8 couples in the US faces difficulty conceiving, i.e., over 12% of married women face complications in attaining pregnancy. According to data published in Medical Lifesciences in 2023, the problem affects ~1 in 7 couples in the UK, totaling ~3.5 million affected individuals. As more people become aware of the various options available to overcome infertility, including surrogacy, the demand for surrogacy services is increasing. Several private and public organizations are spreading awareness of infertility and its treatment through initiatives promoting procedures such as in vitro fertilization (IVF) and intrauterine insemination (IUI). US Fertility urges those struggling with infertility to participate in National Infertility Awareness Week (NIAW) that is observed throughout the last week of April every year. During the NIAW, the Fertility Centres of Illinois (FCI), IVF Florida, Reproductive Science Centre of the San Francisco Bay Area (RSC), and Shady Grove Fertility (SGF) organize physician-hosted events and arrange educational materials to enlighten patients. Further, Europe observes a European Fertility Week every year in November to raise awareness about infertility. Thus, the increasing number of awareness programs related to infertility treatments boosts the surrogacy market in the US and Europe.

High Cost Involved in Procedure is hampering the US and Europe Surrogacy Market Growth

Many individuals and couples opt for international surrogacy arrangements in countries with comparatively lower healthcare costs. Destinations such as India, Ukraine, or certain Southeast Asian countries have emerged as popular choices for individuals seeking more affordable surrogacy options. These countries often offer lower medical costs, less stringent legal requirements, and lower compensation for surrogate mothers, resulting in reduced overall expenses. According to IVF Conception, a medical tourism consultancy, the cost of a surrogacy procedure in India ranges from 12 to 15 lakh INR (US$ 15,000-21,000), which is substantially low compared to the US and East European countries. On the other hand, the typical cost of surrogacy procedures in the US and eastern European countries, such as Ukraine, ranges from US$ 95,000 to 150,000 and from US$ 45,000 to 55,000, respectively.

Legal fees also lead to significant expenses in the surrogacy process. Intended parents need to approach professionals specializing in surrogacy laws to ensure that all legal aspects are properly handled. This includes drafting and reviewing contracts, obtaining necessary permissions and documentation, and navigating a complex legal landscape surrounding surrogacy. In addition, other miscellaneous expenses include travel costs for intended parents, accommodation arrangements, insurance coverage, and additional contingencies arising throughout the journey. These costs can vary depending on individual circumstances and the specific requirements of the arrangement. Thus, the high cost involved in surrogacy can be a barrier for some intended parents, thereby limiting the overall market growth.

A few of the recent developments in the US and Europe surrogacy market are mentioned below:

In March 2023, US Fertility has joined forces with Ovation Fertility to create IVF services powerhouse and increase the access to fertility services. The two companies signed a definitive agreement and have completed a successful federal regulatory evaluation process, creating the leading fertility platform in the U.S. Together, US Fertility and Ovation provide advanced fertility care through 90+ locations and 28 laboratories.

In May 2023, London Women's Clinic opened their new fertility clinic in Colchester. This will allow the company to proudly expand the world-class fertility care through the county of Essex and its surrounding areas.

Type US and Europe Surrogacy Market-Based Insights

The US and Europe surrogacy market, based on type, is segmented into traditional surrogacy and gestational surrogacy. In 2022, the gestational surrogacy segment held the largest market share in US and Europe surrogacy market. The market for the same segment is expected to grow at the fastest rate in the coming years.

Technology US and Europe Surrogacy Market-Based Insights

The US and Europe surrogacy market, based on technology, is segmented into intrauterine insemination and in-vitro fertilization. In 2022, the in-vitro fertilization segment held the largest market share in US and Europe surrogacy market. The market for the same segment is expected to grow at the fastest rate in the coming years.

Age Group US and Europe Surrogacy Market-Based Insights

The US and Europe surrogacy market, based on age group, is segmented into below 35 years, 35-37 years, 38-39 years, 40-42 years, 43-44 years, and over 44 years. In 2022, the below 35 years segment held the largest market share, and the same segment is expected to grow at the fastest rate during the forecast period.

Service Order US and Europe Surrogacy Market-Based Insights

The US and Europe surrogacy market, based on service order, is segmented into hospitals, fertility clinics, and others. In 2022, the fertility clinics segment held the largest market share, and the same segment is expected to grow at the fastest rate during the forecast period.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and to American Fertility Services are a few of the major primary and secondary sources referred to while preparing the report on the US and Europe surrogacy market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the US and Europe surrogacy market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the US and Europe surrogacy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the US and Europe surrogacy market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 US and Europe Surrogacy market - by Type
  • 1.3.2 US and Europe Surrogacy market - by Technology
  • 1.3.3 US and Europe Surrogacy market - by Age Group
  • 1.3.4 US and Europe Surrogacy market - by Service Provider
  • 1.3.5 US and Europe Surrogacy market - by Country

2. US and Europe Surrogacy market - Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. US and Europe Surrogacy market - Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 US - PEST Analysis
  • 4.2.2 Europe - PEST Analysis

5. US and Europe Surrogacy Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increasing Number of Infertility Cases
  • 5.1.2 Growing Awareness of Treatment of Infertility
• 5.2 Market Restraints
  • 5.2.1 High Cost Involved in Procedure
• 5.3 Market Opportunities
  • 5.3.1 Technological Advancements in Reproductive Technologies
• 5.4 Future Trends
  • 5.4.1 Commercialization of Surrogacy
• 5.5 Impact Analysis

6. US and Europe Surrogacy market Analysis

• 6.1 US and Europe Surrogacy market Revenue Forecast and Analysis
• 6.2 Cost Analysis
• 6.3 Regulatory Scenario
  • 6.3.1 United States
  • 6.3.2 Italy
  • 6.3.3 UK
  • 6.3.4 Denmark
  • 6.3.5 The Netherlands
  • 6.3.6 Ireland

7. US and Europe Surrogacy Market Analysis - by Type

• 7.1 Overview
• 7.2 Gestational Surrogacy
  • 7.2.1 Overview
  • 7.2.2 Gestational Surrogacy: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 7.3 Traditional Surrogacy
  • 7.3.1 Overview
  • 7.3.2 Traditional Surrogacy: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)

8. US and Europe Surrogacy Market Analysis - by Technology

• 8.1 Overview
• 8.2 Intrauterine Insemination (IUI)
  • 8.2.1 Overview
  • 8.2.2 Intrauterine Insemination (IUI): US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 8.3 In-Vitro Fertilization (IVF)
  • 8.3.1 Overview
  • 8.3.2 In-Vitro Fertilization (IVF): US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3.3 Classical/Standard IVF
    • 8.3.3.1 Overview
    • 8.3.3.2 Classical/Standard IVF: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3.4 Intracytoplasmic Sperm Injection (ICSI)
    • 8.3.4.1 Overview
    • 8.3.4.2 Intracytoplasmic Sperm Injection (ICSI): US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)

9. US and Europe Surrogacy Market Analysis - by Age Group

• 9.1 Overview
• 9.2 Below 35 Years
  • 9.2.1 Below 35 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 9.3-37 Years
  • 9.3.1-37 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4-39 Years
  • 9.4.1-39 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5-42 Years
  • 9.5.1-42 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6-44 Years
  • 9.6.1-44 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 9.7 Over 44 Years
  • 9.7.1 Over 44 Years: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)

10. US and Europe Surrogacy Market Analysis - by Service Order

• 10.1 Overview
• 10.2 Hospitals
  • 10.2.1 Overview
  • 10.2.2 Hospitals: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 10.3 Fertility Clinics
  • 10.3.1 Overview
  • 10.3.2 Fertility Clinics: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)
• 10.4 Others
  • 10.4.1 Overview
  • 10.4.2 Others: US and Europe Surrogacy Market - Revenue and Forecast to 2030 (US$ Million)

11. US and Europe Surrogacy Market - Regional Analysis

• 11.1 Europe
  • 11.1.1 Overview
  • 11.1.2 Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
  • 11.1.3 Europe Surrogacy Market, by Type, 2020-2030 (US$ Million)
  • 11.1.4 Europe Surrogacy Market, by Technology, 2020-2030 (US$ Million)
    • 11.1.4.1 Europe Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
  • 11.1.5 Europe Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
  • 11.1.6 Europe Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
  • 11.1.7 Europe Surrogacy Market, by Country
    • 11.1.7.1 Italy
      • 11.1.7.1.1 Overview
      • 11.1.7.1.2 Italy Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.7.1.3 Italy Surrogacy Market, by Type, 2020-2030 (US$ Million)
      • 11.1.7.1.4 Italy Surrogacy Market, by Technology, 2020-2030 (US$ Million)
      • 11.1.7.1.4.1 Italy Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
      • 11.1.7.1.5 Italy Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
      • 11.1.7.1.6 Italy Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
    • 11.1.7.2 UK
      • 11.1.7.2.1 Overview
      • 11.1.7.2.2 UK Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.7.2.3 UK Surrogacy Market, by Type, 2020-2030 (US$ Million)
      • 11.1.7.2.4 UK Surrogacy Market, by Technology, 2020-2030 (US$ Million)
      • 11.1.7.2.4.1 UK Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
      • 11.1.7.2.5 UK Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
      • 11.1.7.2.6 UK Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
    • 11.1.7.3 Denmark
      • 11.1.7.3.1 Overview
      • 11.1.7.3.2 Denmark Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.7.3.3 Denmark Surrogacy Market, by Type, 2020-2030 (US$ Million)
      • 11.1.7.3.4 Denmark Surrogacy Market, by Technology, 2020-2030 (US$ Million)
      • 11.1.7.3.4.1 Denmark Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
      • 11.1.7.3.5 Denmark Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
      • 11.1.7.3.6 Denmark Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
    • 11.1.7.4 The Netherlands
      • 11.1.7.4.1 Overview
      • 11.1.7.4.2 The Netherlands Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.7.4.3 The Netherlands Surrogacy Market, by Type, 2020-2030 (US$ Million)
      • 11.1.7.4.4 The Netherlands Surrogacy Market, by Technology, 2020-2030 (US$ Million)
      • 11.1.7.4.4.1 The Netherlands Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
      • 11.1.7.4.5 The Netherlands Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
      • 11.1.7.4.6 The Netherlands Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
    • 11.1.7.5 Ireland
      • 11.1.7.5.1 Overview
      • 11.1.7.5.2 Ireland Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.7.5.3 Ireland Surrogacy Market, by Type, 2020-2030 (US$ Million)
      • 11.1.7.5.4 Ireland Surrogacy Market, by Technology, 2020-2030 (US$ Million)
      • 11.1.7.5.4.1 Ireland Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
      • 11.1.7.5.5 Ireland Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
      • 11.1.7.5.6 Ireland Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
    • 11.1.7.6 Rest of Europe
      • 11.1.7.6.1 Overview
      • 11.1.7.6.2 Rest of Europe Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.7.6.3 Rest of Europe Surrogacy Market, by Type, 2020-2030 (US$ Million)
      • 11.1.7.6.4 Rest of Europe Surrogacy Market, by Technology, 2020-2030 (US$ Million)
      • 11.1.7.6.4.1 Rest of Europe Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
      • 11.1.7.6.5 Rest of Europe Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
      • 11.1.7.6.6 Rest of Europe Surrogacy Market, by Service Order, 2020-2030 (US$ Million)
• 11.2 United States
  • 11.2.1 Overview
  • 11.2.2 US Surrogacy Market Revenue and Forecasts to 2030 (US$ Mn)
  • 11.2.3 US Surrogacy Market, by Type, 2020-2030 (US$ Million)
  • 11.2.4 US Surrogacy Market, by Technology, 2020-2030 (US$ Million)
    • 11.2.4.1 US Surrogacy Market, for IVF by Technology, 2020-2030 (US$ Million)
  • 11.2.5 US Surrogacy Market, by Age Group, 2020-2030 (US$ Million)
  • 11.2.6 US Surrogacy Market, by Service Order, 2020-2030 (US$ Million)

12. Impact Of COVID-19 Pandemic on U.S. and Europe Surrogacy Market

• 12.1 U.S.: Impact Assessment of COVID-19 Pandemic
• 12.2 Europe: Impact Assessment of COVID-19 Pandemic

13. USA & Europe Surrogacy Market - Industry Landscape

• 13.1 Overview
• 13.2 Growth Strategies in USA & Europe Surrogacy Market (%)
• 13.3 Organic Developments
  • 13.3.1 Overview
• 13.4 Inorganic Developments
  • 13.4.1 Overview

14. Company Profiles

• 14.1 London Women's Clinic Ltd
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
• 14.2 The Centre for Reproductive and Genetic Health Ltd
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
• 14.3 Miracle Baby Surrogacy
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
• 14.4 Lotus Surrogacy
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
• 14.5 VittoriaVita LLC
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
• 14.6 Sensible Surrogacy
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
• 14.7 New Life Ukraine
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
• 14.8 Redia Ltd
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
• 14.9 Circle Surrogacy LLC
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
• 14.10 Ovation Fertility
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments

15. Appendix

• 15.1 About The Insight Partners
• 15.2 Glossary of Terms